CCI Calculator
Assess comorbidity burden and estimate 10-year survival probability using the validated CCI scoring system
Age adds 1 point per decade above 40, up to 4 points for age 80 or older
Select all conditions that apply. For tiered conditions, select the highest applicable severity level.
Select the highest applicable severity level. Mild includes chronic hepatitis or well-compensated cirrhosis. Moderate/Severe includes cirrhosis with portal hypertension or a history of variceal bleeding.
Select the highest applicable severity level. Uncomplicated includes well-controlled diabetes without organ damage. End-organ damage includes retinopathy, neuropathy, nephropathy, or brittle diabetes.
Select the highest applicable severity level. Localized means no distant metastases. Metastatic means spread beyond the primary site.
Select Conditions to Calculate CCI
Choose the patient's age bracket and check all applicable comorbid conditions above. Results appear instantly.
Important
This calculator is provided for general information only and is not medical advice, diagnosis, or treatment. Results are estimates based on population averages and cannot account for your individual circumstances. Speak to a qualified healthcare professional before acting on anything you read here.
Assess comorbidity burden and estimate 10-year survival probability using the validated CCI scoring system
The Charlson Comorbidity Index (CCI) is one of the most widely used and validated clinical scoring tools in medicine. First published by Dr. Mary E. Charlson and colleagues in the Journal of Chronic Diseases in 1987, it was designed to predict the one-year mortality risk for patients based on the presence and severity of specific comorbid conditions. Over the decades, the index has been adapted to estimate 10-year survival probability, making it valuable not just for short-term risk assessment but also for long-range prognosis in chronic disease management, surgical planning, and cancer treatment. The index was originally developed by analyzing a cohort of 604 medical patients at the New York Hospital, examining which comorbid conditions independently predicted mortality and how strongly. Nineteen conditions were initially identified, and their individual mortality risks were used to assign numerical weights. Conditions with a relative risk of 1.2 to 1.5 times baseline received a weight of 1 point; conditions with a relative risk of 1.5 to 2.5 received 2 points; a relative risk of 2.5 to 3.5 received 3 points; and conditions with the strongest mortality impact — metastatic solid tumors and AIDS — received 6 points each. The total score is the sum of all applicable condition weights plus an age adjustment. The age adjustment reflects the well-established clinical observation that older patients tolerate comorbidities less well. For every decade of age above 40, one additional point is added. This means a patient aged 50 to 59 receives 1 extra point, someone aged 60 to 69 receives 2, someone aged 70 to 79 receives 3, and someone aged 80 or older receives 4 additional points. Most modern implementations of the CCI include the age adjustment as part of the primary score, and this calculator follows that convention. The 10-year survival estimate is calculated using the formula: Survival (%) = 0.983 raised to the power of e raised to the power of (CCI score times 0.9), then multiplied by 100. This formula was derived from the original Charlson validation cohort and has been confirmed in numerous subsequent studies. A CCI score of 0 corresponds to an approximate 10-year survival of 98%, a score of 1 corresponds to about 89%, a score of 2 to about 79%, a score of 3 to about 64%, and a score of 5 or higher to less than 45%. Three conditions in the CCI require severity-tiered assessment rather than a simple yes or no answer: liver disease, diabetes mellitus, and solid tumors. For liver disease, mild disease such as chronic hepatitis or cirrhosis without portal hypertension earns 1 point, while moderate or severe liver disease such as cirrhosis with portal hypertension or variceal bleeding earns 3 points. For diabetes, uncomplicated diabetes earns 1 point while diabetes with end-organ damage such as retinopathy, neuropathy, nephropathy, or brittle diabetes earns 2 points. For solid tumors, a localized tumor earns 2 points while a metastatic tumor earns 6 points. In all three cases, only the higher applicable level should be counted, not both. This calculator groups the 16 comorbidity conditions into four organ system categories to make navigation easier: cardiovascular and respiratory conditions, neurological conditions, hepatic and renal conditions, and malignant and immunological conditions. This grouping reflects how clinicians typically think about comorbidities when conducting a systematic review of a patient's medical history. The CCI is used in a wide variety of clinical contexts. In oncology, it helps stratify patients for clinical trials and guides decisions about the intensity of treatment regimens. In surgery, it assists in preoperative risk assessment and informs consent discussions about operative risk. In nephrology, it guides decisions about dialysis initiation and transplant eligibility. In population health research, it is used to adjust for case-mix when comparing outcomes across hospitals or patient populations using administrative data such as claims databases. It is critically important to note that the CCI is a statistical tool derived from population-level data and is not intended to replace individualized clinical judgment. The survival estimates it produces reflect average outcomes from historical cohorts and may not accurately predict outcomes for any individual patient. Modern treatments, particularly for cancer and AIDS, have dramatically improved prognosis compared to the 1987 validation era. Clinicians and patients should use the CCI as one input among many in a comprehensive clinical assessment, always consulting with qualified healthcare professionals for personalized medical decisions.
Understanding the Charlson Comorbidity Index
The CCI is a validated scoring system that assigns numerical weights to 16 comorbid conditions based on their independently measured impact on mortality. The total score predicts comorbidity burden and estimates long-term survival probability.
How Condition Weights Were Determined
The weights in the CCI were not assigned arbitrarily. Charlson et al. analyzed 559 medical patients and used multivariate logistic regression to determine which conditions independently predicted one-year mortality and with what relative risk. Conditions with a relative risk of 1.2–1.5 received a weight of 1 point; 1.5–2.5 received 2 points; 2.5–3.5 received 3 points; and dominant mortality drivers like metastatic cancer and AIDS received 6 points. This evidence-based weighting approach is why the CCI has remained clinically relevant for nearly four decades.
The Age Adjustment
Older patients with the same comorbidities as younger patients tend to have worse outcomes, reflecting reduced physiologic reserve and reduced ability to compensate for organ dysfunction. The CCI accounts for this by adding 1 point per decade of age above 40. This means a 55-year-old and a 75-year-old with identical comorbidities will have different CCI scores and different projected survival rates. The age adjustment is typically included in the primary CCI score and is included by default in this calculator.
Tiered Severity Conditions
Three conditions — liver disease, diabetes, and solid tumors — require severity grading rather than a simple yes or no response. This tiered approach reflects the clinical reality that mild chronic hepatitis carries a very different mortality risk than cirrhosis with variceal bleeding, and that localized early-stage cancer has a fundamentally different prognosis than metastatic disease. Only the highest applicable tier should be selected for each of these three conditions.
CCI Score Interpretation and Limitations
A CCI score of 0–1 reflects low comorbidity burden with an estimated 10-year survival above 89%. Scores of 2 indicate moderate burden (~79% survival), scores of 3–4 indicate high burden (53–64% survival), and scores of 5 or higher indicate very high burden with estimated survival below 45%. These estimates are population averages from a 1987 cohort. Modern treatments for AIDS, cancer, and organ failure have improved outcomes considerably, so the survival estimates may be more pessimistic than contemporary clinical reality.
CCI Formulas
Charlson Comorbidity Index (CCI)
CCI = Σ weighted_conditions
Sum of all applicable condition weights. Each of the 16 conditions has a weight of 1, 2, 3, or 6 based on its independently measured relative risk for one-year mortality.
Age-Adjusted CCI
Age-Adjusted CCI = CCI + age_points
Adds 1 point per decade of age above 40: age 50–59 = +1, 60–69 = +2, 70–79 = +3, 80+ = +4. Under 50 = 0 additional points.
10-Year Survival Estimate
Survival(%) = 0.983^(e^(CCI × 0.9)) × 100
Where 0.983 is the baseline survival constant, e is Euler's number (~2.718), and 0.9 is the regression coefficient from the original Charlson 1987 validation cohort.
10-Year Mortality Risk
Mortality(%) = 100 − Survival(%)
Complement of the 10-year survival estimate. A CCI of 0 yields ~2% mortality; CCI of 5 yields ~61% mortality.
CCI Reference Tables
Charlson Conditions and Weights
All 16 scored conditions in the CCI with their assigned weights based on relative risk for one-year mortality from Charlson et al. 1987.
| Condition | Weight | Category |
|---|---|---|
| Myocardial Infarction | 1 | Cardiovascular |
| Congestive Heart Failure | 1 | Cardiovascular |
| Peripheral Vascular Disease | 1 | Cardiovascular |
| Chronic Pulmonary Disease (COPD) | 1 | Cardiovascular/Respiratory |
| Cerebrovascular Disease / TIA | 1 | Neurological |
| Dementia | 1 | Neurological |
| Connective Tissue Disease | 1 | Hepatic/Renal |
| Peptic Ulcer Disease | 1 | Hepatic/Renal |
| Mild Liver Disease | 1 | Hepatic/Renal |
| Uncomplicated Diabetes | 1 | Hepatic/Renal |
| Hemiplegia | 2 | Neurological |
| Moderate to Severe CKD | 2 | Hepatic/Renal |
| Diabetes with End-Organ Damage | 2 | Hepatic/Renal |
| Localized Solid Tumor | 2 | Malignant |
| Leukemia | 2 | Malignant |
| Lymphoma | 2 | Malignant |
| Moderate/Severe Liver Disease | 3 | Hepatic/Renal |
| Metastatic Solid Tumor | 6 | Malignant |
| AIDS | 6 | Immunological |
CCI Score to 10-Year Survival
Estimated 10-year survival probability by CCI score, based on the original Charlson 1987 formula. Modern outcomes may be better for some conditions.
| CCI Score | 10-Year Survival | 10-Year Mortality | Risk Level |
|---|---|---|---|
| 0 | 98% | 2% | Low |
| 1 | 89% | 11% | Low |
| 2 | 79% | 21% | Moderate |
| 3 | 64% | 36% | High |
| 4 | 53% | 47% | High |
| 5 | 39% | 61% | Very High |
| 6 | 27% | 73% | Very High |
| 7 | 18% | 82% | Very High |
| 8+ | <12% | >88% | Very High |
Worked Examples
65-year-old with diabetes, COPD, and prior MI
A 65-year-old male with a history of myocardial infarction, uncomplicated type 2 diabetes, and moderate COPD. No other comorbidities.
Age points: 65 years falls in the 60–69 bracket → +2 points
Myocardial Infarction: weight = 1 point
Uncomplicated Diabetes: weight = 1 point
COPD: weight = 1 point
Raw comorbidity score: 1 + 1 + 1 = 3
Age-adjusted CCI: 3 + 2 = 5
10-year survival: 0.983^(e^(5 × 0.9)) = 0.983^(e^4.5) = 0.983^90.02 ≈ 0.39 (39%)
Age-adjusted CCI = 5 (Very High Risk). Estimated 10-year survival ≈ 39%. This patient's comorbidity burden warrants active management and goals-of-care discussion.
78-year-old with metastatic cancer and CHF
A 78-year-old female with metastatic breast cancer and congestive heart failure. No other conditions.
Age points: 78 years falls in the 70–79 bracket → +3 points
Metastatic Solid Tumor: weight = 6 points (use metastatic, not localized)
Congestive Heart Failure: weight = 1 point
Raw comorbidity score: 6 + 1 = 7
Age-adjusted CCI: 7 + 3 = 10
10-year survival: 0.983^(e^(10 × 0.9)) = 0.983^(e^9.0) = 0.983^8103 ≈ 0% (effectively zero)
Age-adjusted CCI = 10 (Very High Risk). Estimated 10-year survival is effectively 0%. The high score reflects the dominant impact of metastatic cancer (6 pts) combined with advanced age.
52-year-old with mild liver disease and diabetes with nephropathy
A 52-year-old male with mild chronic hepatitis (compensated), type 2 diabetes with nephropathy (proteinuria, eGFR 35). Demonstrate tiered condition scoring.
Age points: 52 years falls in the 50–59 bracket → +1 point
Mild Liver Disease: weight = 1 point (not moderate/severe since no portal hypertension)
Diabetes with End-Organ Damage (nephropathy): weight = 2 points (use the higher tier, not uncomplicated)
Do NOT also count uncomplicated diabetes — only the highest tier applies
Raw comorbidity score: 1 + 2 = 3
Age-adjusted CCI: 3 + 1 = 4
10-year survival: 0.983^(e^(4 × 0.9)) = 0.983^(e^3.6) = 0.983^36.60 ≈ 0.53 (53%)
Age-adjusted CCI = 4 (High Risk). Estimated 10-year survival ≈ 53%. Note that for tiered conditions, only the single highest applicable severity level is counted.
How to Use the CCI Calculator
Select the Patient's Age Bracket
Choose the age bracket that matches the patient's current age. Age adds 0 to 4 points to the total CCI score: no points for age under 50, and 1 additional point for each decade of age from 50 onward up to a maximum of 4 points for age 80 or older.
Review Each Comorbid Condition
Work through all four organ-system groups — cardiovascular and respiratory, neurological, hepatic and renal, and malignant and immunological. Check each condition that applies to the patient. Use the help text beside each condition for the clinical definition used in the original Charlson validation. For simple yes/no conditions, checking the box adds the designated points automatically.
Select Severity for Tiered Conditions
For the three tiered conditions — liver disease, diabetes mellitus, and solid tumor — select the highest severity level that applies. Only one level per condition is counted. For liver disease: none, mild, or moderate/severe. For diabetes: none, uncomplicated, or end-organ damage. For solid tumor: none, localized, or metastatic.
Review Your Results
The total CCI score, 10-year survival estimate, risk category, and per-condition point breakdown are displayed instantly as you make selections. Review the score composition chart to see how each category contributes to the total. Use the export or print options to save the result for documentation purposes.
Frequently Asked Questions
What is the Charlson Comorbidity Index and why is it used?
The Charlson Comorbidity Index (CCI) is a validated clinical scoring system that assigns numerical weights to 16 specific comorbid conditions based on their independently measured impact on one-year mortality. It was developed by Dr. Mary Charlson and colleagues in 1987 through analysis of a large medical patient cohort. The CCI is used to predict long-term survival probability, stratify patients for clinical trials, assess surgical and procedural risk, guide prognosis discussions, and adjust for case-mix in health services research. It has been validated in dozens of independent studies across oncology, cardiology, nephrology, surgery, and primary care, making it one of the most extensively studied comorbidity tools in clinical medicine.
How is the 10-year survival estimate calculated?
The 10-year survival estimate uses the formula: Survival (%) = 0.983 raised to the power of e raised to the power of (CCI × 0.9), multiplied by 100. In this formula, 0.983 is the baseline 10-year survival constant from the original validation cohort, e is Euler's number (approximately 2.718), CCI is the total Charlson score, and 0.9 is the regression coefficient derived from Charlson et al. 1987. A CCI of 0 yields approximately 98% survival; a score of 1 yields about 89%; a score of 2 yields about 79%; a score of 3 yields about 64%; a score of 5 yields about 39%. These are population averages from a historical cohort, not individual predictions.
How do I handle the tiered conditions — liver disease, diabetes, and solid tumor?
For the three tiered conditions, select only the single highest severity level that applies to the patient and count it once. For liver disease: mild disease such as compensated cirrhosis earns 1 point; moderate or severe disease such as cirrhosis with portal hypertension or variceal bleeding earns 3 points — not 1+3. For diabetes: uncomplicated diabetes earns 1 point; diabetes with end-organ damage (retinopathy, neuropathy, nephropathy, or brittle diabetes) earns 2 points. For solid tumors: a localized tumor earns 2 points; a metastatic tumor earns 6 points. Do not count both the mild and severe versions of the same condition.
Are the 10-year survival estimates still accurate given advances in treatment?
The survival estimates reflect population averages from a 1987 cohort treated with the medical therapies of that era. For many conditions, particularly AIDS and certain cancers, modern treatments have dramatically improved outcomes. A patient with well-controlled HIV infection on modern antiretroviral therapy has a very different prognosis than what the 1987 AIDS weight implies. Similarly, targeted therapies and immunotherapy have transformed the prognosis of many solid tumors. The CCI should be interpreted in the context of current treatment options and individual patient circumstances. The estimates are best used as a rough comparative measure of comorbidity burden rather than as precise individual survival predictions.
What is the difference between the raw CCI score and the age-adjusted CCI score?
The raw comorbidity score counts only the points from the 16 disease conditions. The age-adjusted CCI score adds additional points based on the patient's age bracket: 0 points for age under 50, 1 point for age 50–59, 2 points for age 60–69, 3 points for age 70–79, and 4 points for age 80 or older. Most published references and online calculators report the age-adjusted score as the primary CCI score, because including age captures the additional risk that older patients face from the same set of comorbidities. This calculator displays both values so you can see the contribution of age separately from the disease conditions.
Can the CCI be calculated from administrative or claims data?
Yes. A significant body of research has developed ICD-9 and ICD-10 coding algorithms that allow the CCI to be calculated from hospital discharge data, insurance claims, or electronic health records without direct clinical assessment. This approach is used extensively in population health research and comparative effectiveness studies. The original Deyo adaptation (1992) and the Quan adaptation (2005) are the most widely cited administrative versions. However, claims-based algorithms may miss some conditions or misclassify severity, so the resulting score may differ from a clinician-assessed CCI. This calculator is designed for direct clinician or patient input rather than administrative data.
Related Tools
GCS Calculator
Calculate the Glasgow Coma Scale score — neurological status assessment relevant to evaluating dementia and cerebrovascular disease in CCI scoring.
ISS Calculator
Calculate the Injury Severity Score for trauma patients — comorbidity burden (CCI) affects trauma outcomes and recovery potential.
GFR Calculator
Estimate glomerular filtration rate — renal function is key for determining the moderate-to-severe CKD component of the CCI.
BMI Calculator
Assess body mass index — obesity is a risk modifier for many CCI conditions including diabetes, heart failure, and peripheral vascular disease.
Life Expectancy Calculator
Estimate life expectancy based on demographic and lifestyle factors — complements the CCI's 10-year survival estimate with broader longevity projections.